Literature DB >> 9028991

Surgical treatment of hepatocellular carcinoma with biliary tumor thrombi.

K T Mok1, H T Chang, S I Liu, N W Jou, C C Tsai, B W Wang.   

Abstract

Treatment is always abandoned in those HCC with jaundice, because it is usually attributed to the underlying liver cirrhosis and extensive tumor. In this series, 7 cases (0.8%) of HCC with jaundice were caused by bile duct invasion and tumor thrombi (BTT). 57% of cases showed Charcot's triad. 57% of BTT were small HCC, significantly higher than the 1.7% of total cases (p<0.05). The growth pattern of BTT was all spreading type, significantly higher than the 42% of total operation cases (p<0.05). The DNA ploidy of BTT was all aneuploid. 57% of BTT had AFP level higher than 400 IU/ml, but it was 27% in total cases. The prognosis is poor in those treated with palliative tube drainage. Aggressive hepatic resection was proved to be safe and achieved the best results in our limited experience. Choledochotomy to remove tumor thrombi is contraindicated because it easily causes tumor seeding. It is advocated to search BTT for resection from the group of HCC with jaundice.

Entities:  

Mesh:

Year:  1996        PMID: 9028991

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  8 in total

1.  Right hepatectomy in icteric type hepatocellular carcinoma-report of a case and literature review.

Authors:  Neel Shetty; Jayanth Reddy; G Srikanth
Journal:  Indian J Surg Oncol       Date:  2014-02-14

2.  Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.

Authors:  Tomoyuki Abe; Kiyoshi Kajiyama; Norifumi Harimoto; Tomonobu Gion; Ken Shirabe; Takashi Nagaie
Journal:  Int J Surg Case Rep       Date:  2012-03-28

3.  Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi.

Authors:  Chun-Nan Yeh; Yi-Yin Jan; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

4.  Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma.

Authors:  Shu You Peng; Jian Wei Wang; Ying Bin Liu; Xiu Jun Cai; Gui Long Deng; Bin Xu; Hai Jun Li
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

5.  Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery.

Authors:  Hong Zeng; Lei-Bo Xu; Jian-Ming Wen; Rui Zhang; Man-Sheng Zhu; Xiang-de Shi; Chao Liu
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus.

Authors:  Anon Chotirosniramit; Akkaphod Liwattanakun; Worakitti Lapisatepun; Wasana Ko-Iam; Trichak Sandhu; Sunhawit Junrungsee
Journal:  J Hepatocell Carcinoma       Date:  2017-03-07

7.  Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: a systematic review and meta-analysis.

Authors:  Jin-Kai Feng; Zhen-Hua Chen; Yu-Xuan Wu; Kang Wang; Ju-Xian Sun; Zong-Tao Chai; Wei-Xing Guo; Jie Shi; Shu-Qun Cheng
Journal:  Ann Transl Med       Date:  2020-12

8.  Surgical treatment for hepatocellular carcinoma with bile duct invasion.

Authors:  Xu-Guang Hu; Wei Mao; Sung Yeon Hong; Bong-Wan Kim; Wei-Guang Xu; Hee-Jung Wang
Journal:  Ann Surg Treat Res       Date:  2016-02-26       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.